Event-Related Desynchronization/Synchronization in Spinocerebellar Ataxia Type 3 by Aoh, Yu et al.
ORIGINAL RESEARCH
published: 31 July 2019
doi: 10.3389/fneur.2019.00822
Frontiers in Neurology | www.frontiersin.org 1 July 2019 | Volume 10 | Article 822
Edited by:
Vincenzo La Bella,
University of Palermo, Italy
Reviewed by:
Jiu Chen,
Nanjing Medical University, China
Silvana Franceschetti,
Istituto Neurologico Carlo Besta
(IRCCS), Italy
*Correspondence:
Jui-Cheng Chen
andrewtw717@gmail.com
†These authors share first authorship
Specialty section:
This article was submitted to
Neurodegeneration,
a section of the journal
Frontiers in Neurology
Received: 05 June 2018
Accepted: 16 July 2019
Published: 31 July 2019
Citation:
Aoh Y, Hsiao H-J, Lu M-K,
Macerollo A, Huang H-C, Hamada M,
Tsai C-H and Chen J-C (2019)
Event-Related
Desynchronization/Synchronization in
Spinocerebellar Ataxia Type 3.
Front. Neurol. 10:822.
doi: 10.3389/fneur.2019.00822
Event-Related
Desynchronization/Synchronization
in Spinocerebellar Ataxia Type 3
Yu Aoh 1†, Han-Jun Hsiao 1†, Ming-Kuei Lu 1,2, Antonella Macerollo 3, Hui-Chun Huang 2,
Masashi Hamada 4, Chon-Haw Tsai 1,2 and Jui-Cheng Chen 1,2,5*
1Neuroscience Laboratory, Department of Neurology, China Medical University Hospital, Taichung City, Taiwan, 2 School of
Medicine, College of Medicine, China Medical University, Taichung City, Taiwan, 3 Sobell Department of Motor Neuroscience
and Movement Disorders, UCL Institute of Neurology, London, United Kingdom, 4Department of Neurology, Graduate
School of Medicine, The University of Tokyo, Tokyo, Japan, 5Department of Neurology, China Medical University Hsinchu
Hospital, Hsinchu, Taiwan
Introduction: Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant, cerebellar
degeneration predominant disease caused by excessive CAG repeats. We examined
event-related dysynchronization/synchronization (ERD/ERS) in patients with SCA3.
Methods: We assessed ERD/ERS of self-paced voluntary hand movements in 15
patients with genetically proven SCA3 in comparison with healthy controls.
Results: In ERS, a significant interaction effect between group, frequency, and period
(F = 1.591; p = 0.005; ρI = 0.86) was observed. The post-hoc two-tailed independent
t-test showed significant differences in high beta and low beta ERS. By contrast, in
ERD, no apparent differences were observed in the pattern of patients with SCA3 in
comparison with healthy controls (F = 1.01; p = 0.442).
Conclusion: The study revealed a decreased ERS in patients with SCA3, especially
at the frequency of 20–30Hz. This study elucidates the significant role of cerebellum in
motor control.
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INTRODUCTION
Spinocerebellar ataxia type 3 (SCA3, also known as Machado–Joseph disease) is an autosomal
dominant, multisystem neurodegenerative disease caused by excessive CAG repeats (1).
In addition to cerebellar ataxia, the clinical manifestations of SCA3 include dysarthria,
progressive ophthalmoplegia, pyramidal signs, facial or lingual fasciculation, rigidity, dystonia,
polyneuropathy, and lid retraction with bulging eyes. Postmortem studies have disclosed pathologic
changes involving pons, spinocerebellar tract, Clarke column, anterior horn cells, substantia nigra,
and the basal ganglia (2).
Electroencephalography is a non-invasive method that help us understand the pathogenesis
of SCA3. A previous study on movement-related cortical potentials (MRCP) in patients with
SCA3 revealed impaired cortical activation associated with affects the initiation and termination
of voluntary movements (3). It suggested an impairment of the postsynaptic potentials on the
pyramidal cell apical dendrites. The analysis of electroencephalogram (EEG) oscillation recorded
during a motor task (self-paced movement) provided different information about the changes in
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cortical activity related to movement (4, 5), especially the
neurons that involved in cortico-thalamic oscillations or other
remote connectivities. In normal participants, event-related
desynchronization (ERD) and event-related synchronization
(ERS) are considered to indicate the activation and subsequent
recovery of the motor cortex during planning, executing and
completing a movement (4, 5). ERD and ERS are different
responses of neuronal structures in the brain and are both time-
locked to the event. In patients with neurodegenerative disorders,
such as Parkinson’s disease (PD) (6), multiple system atrophy
(7), progressive myoclonic epilepsy (8), focal dystonia (9), and
amyotrophic lateral sclerosis (10), the spatiotemporal pattern of
ERD/ERS is altered. For example, in patients with writer’s cramp,
beta ERD in 20–30Hz frequency bands significantly decreased.
It may postulate the involvement of pyramidal system and basal
ganglion in the genesis of ERD/ERS. However, research on
ERD/ERS changes in patients with impaired cerebellar function
is scant. Moreover, the mechanism through which cerebellar
dysfunction affects the sensorimotor cortical activity is unclear.
Therefore, we focused on the sensori-motor oscillatory changes
in patients with SCA3 to study the information conveyed through
voluntary movements. To the best of our knowledge, this is the
first experiment aiming at understanding the ERD/ERS pattern
changes in patients with SCA3.
Our study examined and elucidated the role of cerebellum
and cortico-cerebellar pathway inmotor control by observing the
ERD/ERS pattern alteration in patients with clinical cerebellar
syndromes caused by SCA3.
MATERIALS AND METHODS
Fifteen healthy human participants (mean age 43 ± 15.8 years, 7
women) and 15 patients with SCA3 (mean age 42 ± 12 years,
TABLE 1 | Demographic data of the study patients with SCA3 and normal controls.
Subject Age Sex Disease
duration
(years)
CAG
repeat
Clinical rating
scale of
Cerebellar
function
Stance/Gait
ataxia
Upper limbs
ataxia
(Right/Left)
Lower limbs
ataxia
(Right/Left)
Limbs
hypotonia
(Right/Left)
Postural
tremor
(Right/Left)
Dysarthria Ocular
movement
1 56 M 7 * 7 1/3 0/1 0/0 0/0 0/1 0 1
2 21 F 7 80 1 0/0 0/0 0/0 0/0 0/0 0 1
3 44 M 30 82 10 0/1 1/1 1/1 0/0 1/1 1 1
4 54 M 40 61 23 4/3 3/3 1/1 0/0 1/0 1 5
5 53 F 1 66 17 1/1 1/1 1/1 1/1 1/1 1 6
6 59 F 17 80 16 3/3 3/3 3/3 1/1 0/0 0 1
7 35 F 0# 82 0 0/0 0/0 0/0 0/0 0/0 0 0
8 31 M 16 78 17 * * * * * * *
9 52 M 15 60 4 * * * * * * *
10 30 M 15 78 18 1/1 2/2 1/1 3/3 1/1 2 1
11 33 F 0# 70 4 0/0 0/1 0/0 0/0 0/0 0 3
12 33 M 8 76 7 1/2 0/1 0/0 0/0 1/1 1 1
13 48 F 3 71 6 1/1 1/1 0/0 0/0 0/0 0 2
14 31 F 4 76 11 1/2 1/1 1/1 0/1 1/1 1 0
15 52 M 14 71 17 2/2 1/2 1/1 1/1 1/1 1 2
*No data available.
#Disease duration being zero means patient was clinically symptom-free.
7 women) were enrolled in this study (Table 1). The patients
included were genetically confirmed to have CAG tri-nucleotide
repeats (mean repeats 69 ± 7). Disease duration was defined
as the period from the first onset of symptoms to the time
patients were included. The mean disease duration was 11.8 ±
11 years. All patients were evaluated by the same neurologist and
were given a total score and sub-scores according to the clinical
rating scale for cerebellar function (11). The mean score of the
participants was 10 ± 7. All participants were right handed, and
all gave their written informed consent. Some of the patients with
SCA3 were previously evaluated in our MRCP study (3). The
experiments conformed to the standards set by the Declaration
of Helsinki and were approved by the China Medical University
Hospital, Taiwan.
EEG/EMG Recording and Preprocessing
During the self-paced palm-lifting task, EEG was recorded
with 28 electrodes (Fp1, Fp2, F7, F3, Fz, F4, F8, FC3,
FCz, FC4, T7, C3, Cz, C4, T8, CP3, CPz, CP4, P7, P3,
Pz, P4, P8, O1, Oz, O2, EOG, and EMG) according to
the international 10–20 system for EEG recording; bipolar
surface EMG electrodes were placed on the right extensor
carpi radialis at a spacing of 4 cm. Each participant was
instructed to lift the right palm approximately every 6 s.
After 1,000 s, ∼60 wrist extension tasks each individual were
recorded. We maintained the electrode impedance at <5 k.
While recording, the sampling rate was set at 1,000Hz and
online filtered with 0.05–70Hz band-pass filter by using an
amplifier (NeuroScan SynAmps, Neurosoft, Inc., Sterling, VA,
USA). After recording, band-pass filter ranging from 1 to
50Hz, resampling with 250Hz, and average reference were
applied during oﬄine data analysis. The preprocessed data
were subjected to an independent component analysis (ICA)
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decomposition by using EEGLAB. In addition, ICA components
representing ocular and muscular artifacts were removed from
the data.
EMG
EMG was analyzed using EEGLAB 13_4_4b toolbox and
MATLAB R2015a. For the chosen onset and offset markers,
oﬄine EMG signals were rectified and normalized using z-
score. The threshold was defined as the absolute z-score
value of >1. After identifying the threshold, the rectified
raw EMG signals were epoched by onset markers between
−50 and 1,000ms and baseline corrected with the mean
value between −3,000 and −2,000ms. Peak amplitudes, peak
latencies, and duration of EMG were collected within the
time window.
Time-Frequency Power Analysis
Computed event-related spectral perturbations (ERSP) were
analyzed through Fast-fourier transformation using a three-cycle
wavelet Hanning-tapered window for providing a continuous
measure of the amplitude of a frequency component (12).
ERSP of the wavelet-transformed epochs were computed for
each stimulus requirement at every time point and wavelet
frequency to yield time–frequency maps. Latency time relative
to the time-locking event and amplification or attenuation
at a given frequency were then illustrated using a color for
each image pixel. After ERSP analysis, the absolute power was
TABLE 2 | The EMG characters of SCA3 & controls.
Duration & Latency Average
Character Duration (ms) Latency (ms) Amplitude (µV)
Normal 265.4 ± 109.0 107.5 ± 37.6 695.4± 434.3
SCA3 311.9 ± 115.9 153.4 ± 70.3 672.2± 300.4
P value 0.27 0.03* 0.87
*P < 0.05.
computed using the equation ersp_abs = 10.∧( ersp{1}10 ), where ersp
is the outcome log spectral differs from baseline which obtain
from ERSP analysis.
ERD/ERS Analysis
ERD/ERS calculation was performed according to the method
of Pfurtscheller and Aranibar (13). The ERD/ERS value was
calculated by averaging the absolute power which obtained from
ERSP analysis according to different range of frequency bands.
The outcome ERD/ERS plots were drew from −3 to 4.5 s. The
baseline period was from −3 to −2 s. The frequency bands of
interest were alpha (8–12Hz), low beta (13–20), and high beta
(20–30) bands. The EEG data were then smoothed at every
150ms in one value.
Statistical Analysis
Multivariate repeated measures analyses of variance was
performed using IBM SPSS (Statistical 22, IBM Corp., USA
software) to assess movement-related power change in C3
electrode in SCA 3. The within-subject factors: frequency [alpha
(8–12Hz), low beta (13–20), and high beta (20–30)] and a given
period (ERD: −3 to 1 s, ERS: 0.5 to 4.5) and between-subject
factor: groups (2 levels: SCA 3 and control) were performed. This
resulted in a 3-way repeated GLM (frequency∗period∗group) in
ERD or ERS analysis separately.
Having identified the interaction effect of
frequency∗period∗Group, we then assessed in a second step
period and group effects in a two-way repeated measures GLM
(Period∗Group) in each frequency band.
Finally, follow-up pairwise comparisons were run to assess the
effect within levels of the group factor (SCA 3 and control). Only
effects with effect sizes>0.35 (based on the intraclass correlation
coefficient: ICC) were considered for follow-up analyses to
avoid reporting non-essential effects (14). Greenhouse-Geisser-
corrected results were reported when assumptions of sphericity
were not met and Bonferroni correction was used for
pairwise comparisons.
Pearson’s correlation coefficient was used to investigate the
correlation between clinical rating scale for cerebellar function
FIGURE 1 | Illustration of processed averaged EMG of Normal and SCA3 during the EEG recording.
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FIGURE 2 | An illustration of averaged event-related spectral perturbation at movement onset (0ms) across all control (B) and SCA3 (A). A clear ERD (color blue)
followed by ERS (color red) was presented in both control and SCA3 groups between alpha and beta range at C3 electrode when epoched between −3 and 4.5 s
with baseline corrected by −3 to −2 s.
and peak ERD/ERS in each band. We further analyzed individual
subscales with the significant band.
RESULTS
The participants were 15 controls and 15 patients with SCA3
(Table 1). No difficulty was experienced by the patients and
controls in completing the tasks. No significant age- or sex-
related differences were observed (p= 0.83; p= 1).
Table 2 shows the EMG peak latency, mean duration, and
amplitude in the two groups. The average rectified EMG duration
and peak amplitude between the two groups were not statistically
different (p = 0.27; p = 0.87). In patients with SCA3, peak
latency was slightly delayed (mean difference= 45.9ms, p= 0.03;
Figure 1).
Among the 15 patients with SCA3, similar to the healthy
controls, we found a clearly detectable temporospatial pattern
of movement-related cortical activities, indicating ERD and ERS
around the movement onset (Figures 2A,B).
ERD Analysis
Multivariate repeated measures analyses of variance was used to
investigate the relative power difference of ERD/ERS. In ERD
(Figure 3A), 3-way repeated GLM (frequency∗period∗group)
were performed. Neither the main effect of group nor interaction
effect of Group∗Frequency was observed, which indicates that
the frequency distribution of ERD was similar in both groups (F
= 0.466; p = 0.630; Table 3). Furthermore, no interaction effect
of Group∗Period was observed, which indicates that the time
course of ERD was similar in both groups (F = 1.318; p= 0.134).
In addition, Group∗Frequency∗Period did not have a significant
interaction effect (F = 1.017; p= 0.442).
ERS Analysis
With the similar statistics, in ERS (Figure 3B), the main effect
of group and interaction effect of Group∗Frequency was not
observed, which indicates that the frequency distribution of ERS
was similar in both groups (F = 1.623; p = 0.206). Furthermore,
no interaction effect of Group∗Period was observed, which
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FIGURE 3 | (A) Averaged power change at movement onset between alpha, low beta, and high beta bands both in normal controls and SCA3 patients. (B) Averaged
power change at movement offset between alpha, low beta, and high beta bands in both control and SCA3 groups. post-hoc independent t-test showed significant
difference in high beta ERS (marked as *).
TABLE 3 | Three-way repeated measure analysis of variance
(frequency*period*group) results in ERD/ERS** between Normal and SCA3.
On-Set
ERD
P-value F Off-Set
ERS
P-value F
Group 0.417 F (1, 28) = 0.680 Group 0.365 F (1, 28) = 0.849
Group*
Frequency
0.630 F (2, 56) = 0.466 Group*
Frequency
0.206 F (2, 56) = 1.623
Group*
Period
0.134 F (49, 1372) = 1.318 Group*
Period
0.923 F (49, 1372) = 0.633
Group*
Frequency*
Period
0.442 F (98, 2744) = 1.017 Group*
Frequency*
Period
0.005* F (98, 2744) = 1.591
*P < 0.05.
**ERD period start from −1 to 1 s, ERS period start from 0.5 to 4.5 s.
indicates that the time course of ERD was similar in both groups
(F = 0.633; p = 0.923). However, a significant interaction effect
of Group∗Frequency∗Period (F = 1.591; p = 0.005; ICC = 0.86)
in Table 3.
In a second step, we further tested the Group∗Period
interaction effect in each frequency band. Only interaction effect
in high beta frequency was significant (alpha F = 0.437; p =
0.994; low beta F = 1.446; p = 0.71; high beta F = 2.191; p =
0.001; ICC= 0.36).
The post-hoc pairwise comparison was focused on high beta
ERS (0.5–4.5s) and showed significant differences as described in
Table 4. Each period represented 150ms after movement offset.
The differences of ERS were noted between P3 ∼ P11 which is
around 1 to 2 s after movement offset.
The correlation between the clinical rating scale for cerebellar
function and high beta ERS was R = 0.44, p = 0.10. We also
assessed the correlation in clinical rating subscale for high beta
ERS.Table 5 shows the clinical rating scale for cerebellar function
and the individual subscale as well as the correlation of high
beta ERS and p-value. No significant correlation was noted in the
clinical score with ERS (Table 5).
DISCUSSION
We demonstrated a prominent reduction of beta ERS, especially
at a frequency of 20–30Hz, in patients with SCA3. However, no
apparent differences were observed in the ERD of the patients
compared with the healthy controls. To our knowledge, this is
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TABLE 4 | The post-hoc two-tailed independent t-tests of ERS (0.5–4.5 s) between SCA3 and control in high beta bands.
Period P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17 P18 P19 P20 P21 P22 P23 P24 P25 P26 P27
High
Beta
0.803 0.642 0.035* 0.016* 0.066** 0.002* 0.024* 0.002* 0.007* 0.056** 0.048* 0.106 0.191 0.269 0.199 0.391 0.284 0.217 0.729 0.394 0.646 0.701 0.533 0.848 0.531 0.833 0.895
Each period represented 150ms after movement offset. The differences of ERS were noted between P3 and P11 which is around 1–2 s after movement offset. *p < 0.05; **P < 0.1. Bold values indicates P < 0.05.
TABLE 5 | Pearson’s correlation of Clinical Rating Scale for Cerebellar Function with high beta ERS.
High beta ERS Clinical rating scale for
cerebellar function
Standing balance Gait ataxia Upper limb ataxia(R) Upper limbs
ataxia L
Lower limb
ataxia(R)
Lower limbs
ataxia L
Correlation 0.440 0.481 0.540 0.525 0.442 0.544 0.544
P-value 0.101 0.096 0.057 0.066 0.131 0.055 0.055
High beta ERS Limbs hypotonia(R) Limbs hypotonia (L) Postural tremor(R) Postural
tremor(L)
Dysarthria Ocular
movement
Correlation −0.067 0.154 0.363 0.152 0.224 0.203
P-value 0.828 0.615 0.223 0.62 0.463 0.506
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the first report on the pattern changes of ERD and ERS in patients
with SCA3.
Brain oscillations are produced by neuronal networks. The
activation and deactivation of these networks can result in
oscillatory changes in the synchrony of cell populations due to
externally or internally paced events and can lead to characteristic
EEG patterns. Two such pattern types were observed: ERD
and ERS (15). ERD and ERS indicate the activation and
subsequent recovery, respectively, of the motor cortex in
normal people while planning, executing, and completing a
movement (4, 5).
Generally, ERD can be interpreted as an electrophysiological
correlate of an increased cortical excitability or an activated
cortical area (16). It is also a reliable marker of increased neuronal
excitability. Various studies have discussed the pathophysiologic
role of ERD in several neurologic diseases, such as PD (6) and
focal dystonia (9). This role may be related to pathophysiological
changes occurring in the basal ganglia, inducing impaired
dopaminergic modulation of cortical activation. In patients
with writer’s cramp, beta ERD in 20–30Hz frequency bands
significantly decreased. The underlying pathophysiology might
be the failure of motor cortical activation secondary to aberrant
basal ganglia inputs (9). In our patients, ERD was comparable
with that in healthy controls. Compared with the aforementioned
basal ganglia disorders, cortical activation represented by ERD is
relatively preserved in patients with SCA3.
ERS indicates the local inhibition of motor cortex below
the resting baseline (17) or excitation removal back to the
baseline level (18) or both (19). ERS in the alpha and/ lower
beta bands represents cortical deactivated state and decreased
information processing (20). Thus, ERS could be regarded the
inhibition or termination signal of motor order. Moreover,
ERS reinforces existing motor states and steady motor output
(21). Because beta oscillations were evident across the cortical-
basal ganglia sensorimotor network, beta ERS was abnormal in
various neurologic diseases. In patients with Alzheimer disease
(22) and stroke (23), the spatiotemporal pattern of beta ERS
is definitely altered due to cortical involvement. Furthermore,
patients with PD (24), paroxysmal kinesigenic dyskinesia (25),
myoclonus-dystonia (26), writer’s cramp27 and Unverricht-
Lundborg disease (8) have decreased beta ERS amplitude.
Moreover, ERS between 10 and 13Hzmay represent a deactivated
cortical area or inhibited cortical network. Meanwhile, induced
beta oscillation(13–35Hz) were found in sensorimotor areas after
voluntarymovement and after somatosensory stimulation, which
might be interpreted as a state of “inhibition” of neural circuitry
in the primary motor cortex (16). In patients with impaired
basal ganglia-cortical motor loop, net dopamine levels modulate
their beta oscillatory activity (27). In addition to the association
between ERS and the defective basal ganglia-cortex motor circuit
resulting in impaired cortical motor inhibition, researchers
also found an association between ERS and the processing of
sensory afference. In patients with PD, beta ERS was significantly
lowered in the patient group after manipulation of sensory
input, voluntary movement and passive movement. Therefore,
the decreased ERS might indicate a deficient sensorimotor
integration in patients with PD (28).
Moreover, a recent study suggested that ERS is related
to processes exercising Bayesian inference in sensorimotor
integration in determining revision or maintenance of the
existing motor plan. Furthermore, the amplitude of ERS indexes
the confidence attributed to feedforward estimations relative to
sensory feedback. In healthy participants, higher ERS amplitude
represents higher confidence in maintaining stable motor output,
whereas lower ERS amplitude indicates lower confidence in
feedforward estimations and the need for adaptive changes
driven by sensory feedback (29).
For optimal movement control, the coordination of inputs
from peripheral sensation, cerebellum, basal ganglia, and
sensorimotor cortical integration is mandatory. Particularly, the
cerebellum plays a significant role in high-order motor control.
Studies have revealed how cerebellar pathways integrate with the
sensory, pyramidal, and extra-pyramidal system. An extensive
cerebellar–pons–cortical pathway was discovered in mice, which
contributed to the fine motor control of the vibrissa system in
order to adjust to the surrounding environment. A zone in the
cerebellar cortex was also identified where primary sensory and
motor cortical inputs converge at the cellular level, providing
the anatomical evidence of the existence of sensorimotor
cortico-cerebellar loops and showing its importance in the fine
control of voluntary movements (30). With the input of both
sensory feedback and motor command, the cerebellum was also
considered to be involved in the estimation of future state in a
dynamic system (31).
Although the cerebellum has a clearly indispensable role in
voluntary motor control, it was not previously investigated with
respect to change in ERS pattern. Our study showed decreased
high beta ERS in patients with SCA3 mainly manifesting with
cerebellar ataxia, indicating a defective inhibition of motor
order, failed reinforcement of current motor state, and impaired
sensorimotor integration causing low confidence in feedforward
estimation to maintain steady motor output, which was most
likely being related to damaged cerebellum and cerebello-
cotrical pathways. A prior study of MRCP in patients with
SCA3 also provided evidence of impaired termination of a
voluntary movement (3). Clinically, this could possibly explain
the imprecise termination of movement in patient with SCA3,
manifesting with overshooting, dysdiadochokinesia, and failure
in performing the finger-chasing test. The present study revealed
the ineligible influence of cerebellum and its projection to the
cortex and motor neural network by observing the significant
reduction of beta ERS. Sensori-motor integration abnormality
may play a role in this finding.
However, the clinical scores did not show an obvious
correlation with patient’s ERS power. This result may be due to
the small sample size or the related small scale of each individual
score in the clinical cerebellar score.
The decreased beta ERS in patients with PD has been
restored through deep brain stimulation or administration
of levodopa, which, from a neurochemical point of view,
indicates that neural circuits interfering with beta ERS might
be partially dopaminergic (7, 27, 32). As explained earlier,
beta ERS could be an indicator of confidence in current
motor state and maintenance of steady motor output. However,
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uncertainty had been discovered to be related to acetylcholine
and norepinephrine signaling (33). Therefore, the elements
comprising beta ERS involved numerous neural networks
and neuromodulators.
The present study has some limitations. First, the statistical
significance notwithstanding, the sample size of the study is
relatively small. A larger sample size is needed for a more
comprehensive evaluation of changes in movement-related
neural activities in patients with SCA3. Second, the clinical rating
scale for cerebellar function (11) included all essential elements
of the clinical picture of a cerebellar patient. However, it was less
frequently used than the scale for the assessment and rating of
ataxia score (SARA) (34) as the total score of clinical rating scale
for cerebellar function placed too much emphasis on oculomotor
manifestations. Last, SCA3 per se is a neurodegenerative disease
with multisystem involvement, including the basal ganglia (35).
Although our patients mainly manifest with cerebellar ataxia and
the clinical signs indicating extrapyramidal system impairment
were not prominent, the interference of beta ERS by the basal
ganglia–cortical pathways could not be eliminated completely.
Additional investigations of ERD/ERS are required in other
neurologic diseases, such as SCA6, that involve solely the
cerebellar system.
In this study, we found a decreased ERS in patients with SCA3,
which represents the involvement of cerebellar system in motor
termination. The reflection of impaired motor deactivation,
sensorimotor integration, or sensory feedforward estimation
may be related to the underlying mechanism. Hitherto,
there are no effective treatments for patients with hereditary
spinocerebellar ataxias. However, a clearer understanding of the
pathophysiologic pathways of SCA3 could possibly prompt novel
understanding for this group of patients in the future.
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